ES2195555T3 - Empleo de composiciones para proporcionar glutamina. - Google Patents

Empleo de composiciones para proporcionar glutamina.

Info

Publication number
ES2195555T3
ES2195555T3 ES99913195T ES99913195T ES2195555T3 ES 2195555 T3 ES2195555 T3 ES 2195555T3 ES 99913195 T ES99913195 T ES 99913195T ES 99913195 T ES99913195 T ES 99913195T ES 2195555 T3 ES2195555 T3 ES 2195555T3
Authority
ES
Spain
Prior art keywords
patient
whey protein
protein
compositions
glutamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99913195T
Other languages
English (en)
Inventor
Julio Boza
Olivier Ballevre
Paul-Andre Finot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2195555(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2195555T3 publication Critical patent/ES2195555T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seasonings (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de proteína de suero de leche o de una fuente proteica que contiene 80 % a 90 % en peso de caseína, 0, 5 % a 2 % en peso de isoleucina, 2 % a 8 % en peso de leucina, 1 % a 5 % en peso de cisteína y 1 % a 5 % en peso de lisina en la preparación de una composición nutricional, administrable por vía enteral, destinada al incremento terapéutico de la concentración de glutamina en el plasma de un mamífero estresado.
ES99913195T 1998-03-31 1999-02-22 Empleo de composiciones para proporcionar glutamina. Expired - Lifetime ES2195555T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98201016 1998-03-31

Publications (1)

Publication Number Publication Date
ES2195555T3 true ES2195555T3 (es) 2003-12-01

Family

ID=8233542

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99913195T Expired - Lifetime ES2195555T3 (es) 1998-03-31 1999-02-22 Empleo de composiciones para proporcionar glutamina.

Country Status (13)

Country Link
US (1) US8178487B2 (es)
EP (1) EP1065947B1 (es)
CN (1) CN1134227C (es)
AT (1) ATE237957T1 (es)
AU (1) AU3142099A (es)
BR (1) BR9909234A (es)
CA (1) CA2326148C (es)
DE (1) DE69907170T2 (es)
DK (1) DK1065947T3 (es)
ES (1) ES2195555T3 (es)
ID (1) ID27818A (es)
PT (1) PT1065947E (es)
WO (1) WO1999049741A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
US6864230B2 (en) 2001-07-31 2005-03-08 Novartis Nutrition Ag Glutamine rich dietary composition
ES2280796T3 (es) * 2002-07-01 2007-09-16 Unilever N.V. Composicion de induccion de la saciedad.
JP4970694B2 (ja) 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
CN100356876C (zh) * 2005-09-30 2007-12-26 北京康比特威创体育新技术发展有限公司 一种促进运动疲劳恢复的饮料
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
NZ572802A (en) 2006-06-15 2012-02-24 Murray Goulburn Coop Co Ltd Formulation comprising whey protein and hydrolysates for improving muscle recovery
WO2009052106A2 (en) * 2007-10-14 2009-04-23 University Of Florida Research Foundation Inc. Formulation to improve gastrointestinal function
EP2165713B1 (en) * 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
US10869843B2 (en) * 2010-11-23 2020-12-22 Chemi Nutra Method for increasing muscle mass and strength
ES2633787T3 (es) * 2012-01-09 2017-09-25 N.V. Nutricia Composición nutritiva enriquecida con glutamina para bebés pretérmino
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CN105101812B (zh) 2013-03-08 2018-04-10 艾斯姆食品公司 大米蛋白补充剂
US11026913B2 (en) 2013-09-05 2021-06-08 Emory University Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
WO2015154251A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them.
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
FI904074A7 (fi) * 1989-08-28 1991-03-01 Milupa Ag Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
JP2907603B2 (ja) * 1991-09-09 1999-06-21 雪印乳業株式会社 新規生理活性ペプチド、該活性ペプチドを有効成分とする胃酸分泌抑制剤、抗潰瘍剤及び飲食品
JPH07255398A (ja) * 1994-03-16 1995-10-09 Snow Brand Milk Prod Co Ltd 保存安定性及び嗜好性の高い経口経腸栄養組成物
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
US5661123A (en) * 1995-01-17 1997-08-26 Nestec, Ltd. Enteral composition for malabsorbing patients
DE19717195C2 (de) * 1997-04-24 2001-09-27 Reichenauer Feil Andrea Instantpulver und daraus herstellbares Getränk
AU7764798A (en) 1997-06-02 1998-12-21 Societe Des Produits Nestle S.A. Product and method for providing glutamine
US5849335A (en) * 1997-06-02 1998-12-15 Nestec S.A. Composition and method for providing glutamine
US6019999A (en) * 1997-12-03 2000-02-01 Miller; David F. Process for making liposomal ion-exchange whey protein and products thereof
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition

Also Published As

Publication number Publication date
WO1999049741A1 (en) 1999-10-07
ID27818A (id) 2001-04-26
EP1065947B1 (en) 2003-04-23
DE69907170D1 (de) 2003-05-28
US20090075862A1 (en) 2009-03-19
CN1134227C (zh) 2004-01-14
ATE237957T1 (de) 2003-05-15
AU3142099A (en) 1999-10-18
CA2326148A1 (en) 1999-10-07
US8178487B2 (en) 2012-05-15
DK1065947T3 (da) 2003-07-14
PT1065947E (pt) 2003-08-29
BR9909234A (pt) 2000-11-28
CA2326148C (en) 2008-01-29
HK1039729A1 (en) 2002-05-10
CN1303238A (zh) 2001-07-11
DE69907170T2 (de) 2004-03-11
EP1065947A1 (en) 2001-01-10

Similar Documents

Publication Publication Date Title
BR9909234A (pt) Método para fornecimento de glutamina
BR9710586A (pt) Composição para administração entérica, processos para intensificar a resistência fìsica de um mamìfmamìfero, para o tratamento de osteoporose em um ser humano, para o tratamento de catabiolismo em um ser humano, causado pela aidas ou pelo câncer e para melhorar os efeitos do exercìcio fìsico, e, composição proteica anabólica.
BRPI0412411A (pt) tetrahidro-1h-pirazol[3,4-c]piridinas substituìdas, composições que as contêm e utilização
BRPI0408490A (pt) composições que compreendem ácidos graxos e aminoácidos
WO2004024068A3 (en) Novel composition and methods for the treatment of immune related diseases
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
MXPA05013645A (es) Nuevos compuestos moduladores de los receptores de tipo ppar gama y su utilizacion en composiciones cosmeticas o farmaceuticas.
BR0314666A (pt) Composição nutricional ou terapêutica utilizável para o tratamento de mamìferos para aumentar a atividade imune e método de tratar um mamìfero para aumentar a concentração de glutationa no tecido no referido mamìfero
ATE373082T1 (de) Pre-adipose zelllinien
BRPI0410391A (pt) derivados (2-hidróxi-2-(4-hidróxi-3-hidroximetilfenil)-etilamino)- propilfenila como agonistas beta2
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
BR0312537A (pt) Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
BR9702144A (pt) Compostos propinil biaromáticos composição farmacêutica composição cosmética e utilização de uma composição cosmética
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
BRPI0417093A (pt) composição para consumo animal, método para aumentar a palatabilidade de uma composição de ração, método para aumentar a ingestão de uma ração por um animal, processo para a preparação de uma composição para consumo animal, e, refeição e brinquedo para animal
ATE334685T1 (de) Verwendung von phosphatidylserin zur behandlung des aufmerksamkeits-defizit-syndroms (adhs)
NO20010940D0 (no) TAN-1057 derivater
BR9916549A (pt) Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal
ATE357934T1 (de) Pharmazeutische zusammensetzung zur verhinderung der entwicklung und progression von mykotischen hautoberflächenerkrankungen
DE50304242D1 (de) Verfahren zur herstellung von acylphosphinoxiden